United States HR 3160: Pharmaceutical Research Transparency Act of 2023

Status: Referred to the Subcommittee on Health. (as of 2023-05-12)

State: United States · Session: 118 · Bill: HR 3160

Sponsors: Jamie Raskin, Elissa Slotkin

View United States HR 3160 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.